Nippon India Pharma Fund vs SBI Healthcare Opportunities Fund compare
SBI Healthcare Opportunities Fund - Regular Plan -Growth
Nippon India Pharma Fund-Growth Plan-Growth Option
Chart Comparison
Overview
Scheme Name | SBI Healthcare Opportunities Fund - Regular Plan -Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
Fund | SBI Healthcare Opportunities Fund - Regular Plan -Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
Investment Plan | Growth | Growth |
Level of Risk | Very High | Very High |
Asset Size (Cr) | ₹4027 Cr | ₹8737 Cr |
Min Investment | ₹5000 | ₹5000 |
Min SIP Invesment | ₹500 | ₹500 |
Min Addl Investment | ₹1000 | ₹1000 |
Launch Date | 31 Dec 2004 | 05 Jun 2004 |
Category | Pharma & Healthcare | Pharma & Healthcare |
Fund Type | Open Ended | Open Ended |
Benchmark | BSE Healthcare | BSE Healthcare |
Turn Over | 32% | 21% |
Expense Ratio | 1.94 | 1.82 |
Manager | Pradeep Kesavan | Sailesh Raj Bhan |
ISIN Code | INF200K01446 | INF204K01968 |
Exits Load | SBI Healthcare Opportunities Fund - Regular Plan - Growth charges 0.5% of sell value; if fund sold before 15 days. There are no other charges./365 | Nippon India Pharma Fund - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
Scheme Name | SBI Healthcare Opportunities Fund - Regular Plan -Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
1 Month | -0.99% | -0.67% |
6 Month | 9.73% | 10.26% |
1 Year | 10.33% | 3.59% |
3 Year | 27.12% | 23.06% |
5 Year | 20.45% | 18.54% |
SIP Return Analysis
Scheme Name | SBI Healthcare Opportunities Fund - Regular Plan -Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
6 Month | 3.36% | 4.46% |
1 Year | 7.57% | 7.63% |
3 Year | 25.09% | 22.46% |
5 Year | 21.31% | 18.88% |
Rolling Lumpsum Returns
Scheme Name | SBI Healthcare Opportunities Fund - Regular Plan -Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
1 Year | 16.04% | 17.31% |
3 Year | 17.71% | 20.52% |
5 Year | 12.85% | 20.64% |
Risk Management
Scheme Name | SBI Healthcare Opportunities Fund - Regular Plan -Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
Standard Deviation | 13.57% | 14.61% |
Sharp | 1.42% | 1.14% |
Beta | 0.84% | 0.90% |
Alpha | 4.50% | 0.72% |
Fund Managers
Scheme Name | SBI Healthcare Opportunities Fund - Regular Plan -Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
Name | Pradeep Kesavan | Sailesh Raj Bhan |
Total AUM | ₹434274 Cr | ₹96086 Cr |
Funds Managed | 43 | 5 |
SBI Healthcare Opportunities Fund - Regular Plan -Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
Market Cap
Scheme Name |
SBI Healthcare Opportunities Fund - Regular Plan -Growth |
Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
Others | 12.03 | 1.47 |
Mid Cap | 27.95 | 32.06 |
Small Cap | 33.75 | 31.79 |
Large Cap | 26.26 | 34.68 |
Sector Allocation
Scheme Name |
SBI Healthcare Opportunities Fund - Regular Plan -Growth |
Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
Others | 2.38 | 0.55 |
Basic Materials | 5.96 | - |
Healthcare | 91.66 | 99.45 |
Top Comparisons
Franklin India Flexi Cap Fund - Growth
3Y Returns19%
UTI Flexi Cap Fund - Growth Option
3Y Returns10.3%
ICICI Prudential Quant Fund Growth
3Y Returns17.19%
Kotak Pioneer Fund- Regular Plan- Growth Option
3Y Returns21.55%
ICICI Prudential Multicap Fund - Growth
3Y Returns20.76%
HSBC Multi Cap Fund - Regular - Growth
3Y Returns0%
Franklin India Aggressive Hybrid Fund - Growth Plan
3Y Returns15.21%
Nippon India Aggressive Hybrid Fund - Regular - Growth
3Y Returns15.66%